Does giving up substance use work for patients with psychosis? A systematic meta-analysis

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 9, 2012, Pages 826-839

  Mullin, Katherine ^a   Gupta, Pal ^a   Compton, Michael T ^b   Nielssen, Olav ^c,d,e   Harris, Anthony ^e,f   Large, Matthew ^a,c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f WESTMEAD HOSPITAL   (Australia)

Author keywords

Cannabis; meta analysis; psychosis; schizophrenia; substance use

Indexed keywords

DEPRESSION; EMBASE; EMPLOYMENT STATUS; FOLLOW UP; HUMAN; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; POSITIVE SYNDROME; PSYCHOSIS; PUBLICATION; REVIEW; SOCIAL DISABILITY; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; ADDICTION; ARTICLE; PSYCHOLOGICAL ASPECT; SEVERITY OF ILLNESS INDEX;

HUMANS; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 84873711515     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412440192     Document Type: Review

References (57)

1. Addington J, Addington D. Effect of substance misuse in early psychosis. British Journal of Psychiatry Supplement. 1998 ; 172: 134-136
2. Baeza I, Graell M, Moreno D, et al. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophrenia Research. 2009 ; 113: 129-137
3. Baker AL, Hides L, Lubman DI. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review. Journal of Clinical Psychiatry. 2010 ; 71: 247-254
4. Barnes TR, Mutsatsa SH, Hutton SB, et al. Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry. 2006 ; 188: 237-242
5. Bartels SJ, Teague GB, Drake RE, et al. Substance abuse in schizophrenia: service utilization and costs. Journal of Nervous and Mental Disease. 1993 ; 181: 227-232
6. Bennett ME, Bellack AS, Brown CH, et al. Substance dependence and remission in schizophrenia: a comparison of schizophrenia and affective disorders. Addictive Behaviors. 2009 ; 34: 806-814
7. Borenstein M, Hedges LV, Higgins JPT, et al Introduction to Meta-Analysis. Chichester: John Wiley & Sons, Ltd ; 2009
8. Carey KB, Carey MP, Simons JS. Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status. Journal of Nervous and Mental Disease. 2003 ; 191: 300-308
9. Carra G, Johnson S. Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review. Social Psychiatry and Psychiatric Epidemiology. 2009 ; 44: 429-447
10. Compton MT, Kelley ME, Ramsay CE, et al. Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. American Journal of Psychiatry. 2009 ; 166: 1251-1257
11. Cooper H, Hedges L, Valentine JC The Handbook of Research Synthesis and Meta-analysis. 2009 ) The Handbook of Research Synthesis and Meta-analysis. 2nd edition. New York: Russell Sage Foundation. New York: Russell Sage Foundation ; 2009
12. Cuffel BJ, Chase P. Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study. Journal of Nervous and Mental Disease. 1994 ; 182: 342-348
13. Dixon L, Haas G, Weiden PJ, et al. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry. 1991 ; 148: 224-230
14. Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry. 2009 ; 66: 152-161
15. Fazel S, Gulati G, Linsell L, et al. Schizophrenia and violence: systematic review and meta-analysis. PLoS Med. 2009 ; 6: e1000120
16. Fowler IL, Carr VJ, Carter NT, et al. Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin. 1998 ; 24: 443-455
17. Gonzalez-Pinto A, Alberich S, Barbeito S, et al. Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophrenia Bulletin. 2011 ; 37: 631-639
18. Grech A, Van Os J, Jones PB, et al. Cannabis use and outcome of recent onset psychosis. European Psychiatry. 2005 ; 20: 349-353
19. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biological Psychiatry. 1996 ; 40: 1155-1163
20. Harris AW, Large MM, Redoblado-Hodge A, et al. Clinical and cognitive associations with aggression in the first episode of psychosis. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 85-93
21. Harrison I, Joyce EM, Mutsatsa SH, et al. Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study. Psychological Medicine. 2008 ; 38: 79-88
22. Henquet C, Murray R, Linszen D, et al. The environment and schizophrenia: the role of cannabis use. Schizophrenia Bulletin. 2005 ; 31: 608-612
23. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003 ; 327: 557-560
24. Hinton M, Edwards J, Elkins K, et al. Reductions in cannabis and other illicit substance use between treatment entry and early recovery in patients with first-episode psychosis. Early Intervention in Psychiatry. 2007 ; 1: 259-266
25. Kamali M, Kelly L, Gervin M, et al. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatrica Scandinavica. 2000 ; 101: 452-456
26. Kavanagh DJ, Waghorn G, Jenner L, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research. 2004 ; 66: 115-124
27. Kivlahan DR, Heiman JR, Wright RC, et al. Treatment cost and rehospitalization rate in schizophrenic outpatients with a history of substance abuse. Hospital & Community Psychiatry. 1991 ; 42: 609-614
28. Korver N, Nieman DH, Becker HE, et al. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 230-236
29. Koskinen J, Lohonen J, Koponen H, et al. Prevalence of alcohol use disorders in schizophrenia - a systematic review and meta-analysis. Acta Psychiatrica Scandinavica. 2009a ; 120: 85-96
30. Koskinen J, Lohonen J, Koponen H, et al. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin. 2009b ; 36: 1115-1130
31. Kovasznay B. Substance abuse among veterans with a diagnosis of schizophrenia. Hospital & Community Psychiatry. 1991 ; 42: 948-949
32. Large M, Sharma S, Compton MT, et al. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Archives of General Psychiatry. 2011 ; 68: 555-561
33. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009 ; 6: e1000100
34. Machielsen M, van der Sluis S, de Haan L. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 721-728
35. McMillan KA, Enns MW, Cox BJ, et al. Comorbidity of Axis I and II mental disorders with schizophrenia and psychotic disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Canadian Journal of Psychiatry. 2009 ; 54: 477-486
36. Maremmani I, Lazzeri A, Pacini M, et al. Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status. Journal of Psychoactive Drugs. 2004 ; 36: 235-241
37. Margolese HC, Malchy L, Negrete JC, et al. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research. 2004 ; 67: 157-166
38. Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR. Cannabis consumption as a prognostic factor in schizophrenia. British Journal of Psychiatry. 1994 ; 164: 679-681
39. Mauri MC, Volonteri LS, De Gaspari IF, et al. Substance abuse in first-episode schizophrenic patients: a retrospective study. Clinical Practice and Epidemiology in Mental Health. 2006 ; 2: 4
40. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007 ; 370: 319-328
41. Negrete JC, Knapp WP. The effects of cannabis use on the clinical condition of schizophrenics. National Institute on Drug Abuse Research Monograph. 1986 ; 67: 321-327
42. Novick D, Haro JM, Suarez D, et al. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research. 2010 ; 176: 109-113
43. Pencer A, Addington J. Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience. 2003 ; 28: 48-54
44. Perkins DO, Gu H, Weiden PJ, et al. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. Journal of Clinical Psychiatry. 2008 ; 69: 106-113
45. Peters BD, de Koning P, Dingemans P, et al. Subjective effects of cannabis before the first psychotic episode. Australian and New Zealand Journal of Psychiatry. 2009 ; 43: 1155-1162
46. Rabinowitz J, Bromet EJ, Lavelle J, et al. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychological Medicine. 1998 ; 28: 1411-1419
47. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990 ; 264: 2511-2518
48. Sorbara F, Liraud F, Assens F, et al. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. European Psychiatry. 2003 ; 18: 133-136
49. Stain HJ, Clark S, O'Donnell M, et al. Young rural people at risk for schizophrenia: time for mental health services to translate research evidence into best practice of care. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 872-882
50. Talamo A, Centorrino F, Tondo L, et al. Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophrenia Research. 2006 ; 86: 251-255
51. Turkington A, Mulholland CC, Rushe TM, et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. British Journal of Psychiatry. 2009 ; 195: 242-248
52. Wade D, Harrigan S, Edwards J, et al. Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophrenia Research. 2006a ; 81: 145-150
53. Wade D, Harrigan S, Edwards J, et al. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry. 2006b ; 189: 229-234
54. Wade D, Harrigan S, McGorry PD, et al. Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. Journal of Clinical Psychiatry. 2007 ; 68: 767-774
55. Wisdom JP, Manuel JI, Drake RE. Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment. Psychiatric Services. 2011 ; 62: 1007-1012
56. Yee NY, Large MM, Kemp RI, et al. Severe non-lethal violence during psychotic illness. Australian and New Zealand Journal of Psychiatry. 2011 ; 45: 466-472
57. Yucel M, Bora E, Lubman DI, et al. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin. 2010 ;: